Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 259

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors

Rilke, Franco, Colnaghi, Maria Ines, Cascinelli, Natale, Andreola, Salvatore, Baldini, Maria Teresa, Bufalino, Rosaria, Porta, Giuseppe Della, Ménard, Sylvie, Pierotti, Marco A., Testori, Alessandro·1991·International Journal of Cancer

Abstract

Archival surgical specimens from 1,210 female breast cancer patients treated between 1968 and 1971 and with a 19‐year follow‐up were reanalyzed with special reference to several parameters, such as size of the primary tumor, axillary nodal involvement, histologic grade, degree of inflammatory infiltrate (LPI) of the tumor and expression of the neu onco‐protein (p185) as detected by immunohistochemistry. In a multifactorial analysis the 4 former factors were found to be independent prognostic parameters. Over‐expression of p 185 was found to be related to tumor size and grade and to LPI but not to pathologic nodal status. Over‐expression of p185 showed a negative impact upon survival in node‐positive but not in node‐negative patients. However, in the subset of node‐negative patients without LPI, p185 over‐expression showed the same correlation with a poor prognosis as in node‐positive patients. In contrast, in node‐negative and LPI‐positive patients, p185 over‐expression correlated with a good prognosis. Also, the prognosis of patients with positive nodes, presence of LPI and no p185 over‐expression was similar to that of patients with negative nodes, absence of LPI and p185 over‐expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.2910490109

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 259

Metadata

Authors
Rilke, F., Colnaghi, M. I., Cascinelli, N., Andreola, S., Baldini, M. T., Bufalino, R., Porta, G. D., Ménard, S., Pierotti, M. A., & Testori, A.
Venue
International Journal of Cancer
Publisher
Wiley
Published
1991-08-19
Volume
49
Issue
1
Pages
44-49
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W1994793713
Cited by
259
References
19
FWCI
5.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors. https://app.cochat.ai/papers/10.1002/ijc.2910490109
The paper
Rilke, F., Colnaghi, M. I., Cascinelli, N., Andreola, S., Baldini, M. T., Bufalino, R., Porta, G. D., Ménard, S., Pierotti, M. A., & Testori, A. (1991). Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors. International Journal of Cancer. https://doi.org/10.1002/ijc.2910490109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.